Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...

A newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.

The following is an English translation of an article originally published in Spanish in Salud con Lupa. Para leer este artículo en español, haga clic aquí. Peru's Ministry of Health ...

Merck MRK-1.27%decrease; red down pointing triangle is shaking up the leadership of its main pharmaceutical unit as the U.S. drugmaker braces for sales pressure later this decade. The Rahway, ...

If you’ve ever thought about taking GLP-1 drugs like Ozempic, you might have been scared off by the possibility of thyroid cancer. Recent research, however, finds that this potential danger could ...

A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this ...

Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune ...

The drug makes prostate cancer easier to detect and stage because it attaches to the cancer cells themselves. This marks the third PSMA‑targeted radiopharmaceutical manufactured at Huntsman Cancer ...

Share on Pinterest Could an experimental drug trio fight difficult-to-treat pancreatic cancer? Experiments in mouse models show promise. Image credit: adamkaz/Getty Images Pancreatic ductal ...

Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...

Merck (MRK) has ended discussions about a potential acquisition of biotech firm Revolution Medicines, The Wall Street Journal reported Sunday, citing people familiar with the situation. The ...